Scott Throner
Electrician in Wilmington, DE
License number
Delaware TH-0003436
Issued Date
May 25, 2007
Expiration Date
May 25, 2008
Category
Electrical Examiners
Type
Homeowner's Permit
Address
Address
2
Wilmington, DE 19805
Professional information
Substituted Amino-Pyrimidones And Uses Thereof
US Patent:
2009006, Mar 5, 2009
Filed:
Oct 14, 2005
Appl. No.:
11/577154
Inventors:
Jeffrey Scott Albert - Wilmington DE, US
Don Andisik - Wilmington DE, US
James Arnold - Wilmington DE, US
Dean Brown - Wilmington DE, US
Owen Callaghan - Den Bosch, NL
James Campbell - Wilmington DE, US
Robin Arthur Ellis Carr - Bassingbourn, GB
Gianni Chessari - Cambridge, GB
Miles Stuart Congreve - Cambridge, GB
Phil Edwards - Wilmington DE, US
James R. Empfield - Wilmington DE, US
Martyn Frederickson - Cambridge, GB
Gerard M. Koether - Wilmington DE, US
Jennifer Krumrine - Wilmington DE, US
Russ Mauger - Wilmington DE, US
Christopher William Murray - Cambridge, GB
Sahil Patel - Cambridge, GB
Mark Sylvester - Wilmington DE, US
Scott Throner - Wilmington DE, US
Don Andisik - Wilmington DE, US
James Arnold - Wilmington DE, US
Dean Brown - Wilmington DE, US
Owen Callaghan - Den Bosch, NL
James Campbell - Wilmington DE, US
Robin Arthur Ellis Carr - Bassingbourn, GB
Gianni Chessari - Cambridge, GB
Miles Stuart Congreve - Cambridge, GB
Phil Edwards - Wilmington DE, US
James R. Empfield - Wilmington DE, US
Martyn Frederickson - Cambridge, GB
Gerard M. Koether - Wilmington DE, US
Jennifer Krumrine - Wilmington DE, US
Russ Mauger - Wilmington DE, US
Christopher William Murray - Cambridge, GB
Sahil Patel - Cambridge, GB
Mark Sylvester - Wilmington DE, US
Scott Throner - Wilmington DE, US
Assignee:
AstraZeneca AB - Sodertalje
International Classification:
A61K 31/5377, C07D 239/22, A61K 31/513, C12N 9/99, A61P 25/28, C07D 413/10
US Classification:
5142358, 544321, 514272, 544123, 435184
Abstract:
This invention relates to novel compounds having the structural formula Ia or formula Ib below: (Ia, Ib), and their pharmaceutically acceptable salts, tautomers or in vivo hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of Aβ related pathologies such as cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.
Substituted Amino-Compounds And Uses Thereof
US Patent:
2009022, Sep 3, 2009
Filed:
Oct 14, 2005
Appl. No.:
11/577155
Inventors:
Jeffrey Scott Albert - Wilmington DE, US
Don Andisik - Wilmington DE, US
James Arnold - Wilmington DE, US
Dean Brown - Wilmington DE, US
Owen Callaghan - Den Bosch, NL
James Campbell - Wilmington DE, US
Robin Arthur Ellis Carr - Bassingbourn, GB
Gianni Chessari - Cambridge, GB
Miles Stuart Congreve - Cambridge, GB
Phil Edwards - Wilmington DE, US
James R. Empfield - Wilmington DE, US
Martyn Frederickson - Cambridge, GB
Gerard M. Koether - Wilmington DE, US
Jennifer Krumrine - Wilmington DE, US
Russ Mauger - Wilmington DE, US
Christopher William Murray - Cambridge, GB
Sahil Patel - Cambridge, GB
Mark Sylvester - Wilmington DE, US
Scott Throner - Wilmington DE, US
Don Andisik - Wilmington DE, US
James Arnold - Wilmington DE, US
Dean Brown - Wilmington DE, US
Owen Callaghan - Den Bosch, NL
James Campbell - Wilmington DE, US
Robin Arthur Ellis Carr - Bassingbourn, GB
Gianni Chessari - Cambridge, GB
Miles Stuart Congreve - Cambridge, GB
Phil Edwards - Wilmington DE, US
James R. Empfield - Wilmington DE, US
Martyn Frederickson - Cambridge, GB
Gerard M. Koether - Wilmington DE, US
Jennifer Krumrine - Wilmington DE, US
Russ Mauger - Wilmington DE, US
Christopher William Murray - Cambridge, GB
Sahil Patel - Cambridge, GB
Mark Sylvester - Wilmington DE, US
Scott Throner - Wilmington DE, US
International Classification:
A61K 31/5377, C07D 239/47, A61K 31/513, C07D 413/10, C12N 9/99, A61P 25/28
US Classification:
5142358, 544321, 514272, 544123, 435184
Abstract:
This invention relates to novel compounds having the structural formula Ia or formula Ib: Ia Ib and their pharmaceutically acceptable salts, tautomers or in vivo hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of Aβ related pathologies such as cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.
Cyclopropyl Amide Derivatives '978
US Patent:
2012006, Mar 15, 2012
Filed:
Nov 21, 2011
Appl. No.:
13/300877
Inventors:
James Arnold - San Francisco CA, US
Andrew Todd Brugel - Wilmington DE, US
Scott Throner - Wilmington DE, US
Steven Wesolowski - Wilmington DE, US
Phil Edwards - Kennett Square PA, US
Andrew Griffin - Quebec, CA
Thierry Groblewski - Quebec, CA
Denis Labrecque - Quebec, CA
Andrew Todd Brugel - Wilmington DE, US
Scott Throner - Wilmington DE, US
Steven Wesolowski - Wilmington DE, US
Phil Edwards - Kennett Square PA, US
Andrew Griffin - Quebec, CA
Thierry Groblewski - Quebec, CA
Denis Labrecque - Quebec, CA
International Classification:
A61K 31/551, C07D 223/04, C07D 403/10, C07D 401/10, A61P 25/22, A61P 25/28, A61P 25/18, A61P 3/04, A61P 25/00, C07D 241/04, A61K 31/497
US Classification:
514218, 544391, 540607, 544370, 544372, 544371, 544360, 544357, 51425501, 51425405, 51425401, 51425301, 51425214
Abstract:
Disclosed herein is at least one cyclopropyl amide derivative, at least one pharmaceutical composition comprising at least one cyclopropyl amide derivative disclosed herein, and at least one method of using at least one cyclopropyl amide derivative disclosed herein for treating at least one histamine H3 receptor associated condition therewith.
Cyclopropyl Amide Derivatives
US Patent:
8063215, Nov 22, 2011
Filed:
Aug 21, 2008
Appl. No.:
12/195454
Inventors:
James Arnold - San Francisco CA, US
Todd Andrew Brugel - Wilmington DE, US
Scott Throner - Wilmington DE, US
Steven Wesolowski - Wilmington DE, US
Phil Edwards - Kennett Square PA, US
Andrew Griffin - Québec, CA
Thierry Groblewski - Québec, CA
Denis Labrecque - Québec, CA
Todd Andrew Brugel - Wilmington DE, US
Scott Throner - Wilmington DE, US
Steven Wesolowski - Wilmington DE, US
Phil Edwards - Kennett Square PA, US
Andrew Griffin - Québec, CA
Thierry Groblewski - Québec, CA
Denis Labrecque - Québec, CA
Assignee:
AstraZeneca AB - Sodertalje
International Classification:
C07D 241/04, C07D 295/00
US Classification:
544391
Abstract:
Disclosed herein is at least one cyclopropyl amide derivative, at least one pharmaceutical composition comprising at least one cyclopropyl amide derivative disclosed herein, and at least one method of using at least one cyclopropyl amide derivative disclosed herein for treating at least one histamine H3 receptor associated condition therewith.
Metabotropic Glutamate Receptor Isoxazole Ligands And Their Use As Potentiators—286
US Patent:
7781434, Aug 24, 2010
Filed:
Oct 8, 2009
Appl. No.:
12/575891
Inventors:
Joseph Cacciola - Wilmington DE, US
James Empfield - Wilmington DE, US
James Folmer - Wilmington DE, US
Angela M Hunter - Wilmington DE, US
Scott Throner - Wilmington DE, US
James Empfield - Wilmington DE, US
James Folmer - Wilmington DE, US
Angela M Hunter - Wilmington DE, US
Scott Throner - Wilmington DE, US
Assignee:
AstraZeneca AB - Sodertalje
International Classification:
A61K 31/5377, C07D 413/14
US Classification:
5142352, 544140
Abstract:
Compounds in accord with Formula I:.
Metabotropic Glutamate Receptor Isoxazole Ligands And Their Use As Potentiators 286
US Patent:
7790760, Sep 7, 2010
Filed:
Jun 3, 2009
Appl. No.:
12/477347
Inventors:
Joseph Cacciola - Wilmington DE, US
James Empfield - Wilmington DE, US
James Folmer - Wilmington DE, US
Angela M. Hunter - Wilmington DE, US
Scott Throner - Wilmington DE, US
James Empfield - Wilmington DE, US
James Folmer - Wilmington DE, US
Angela M. Hunter - Wilmington DE, US
Scott Throner - Wilmington DE, US
Assignee:
AstraZeneca AB - Sodertalje
International Classification:
A61K 31/422, C07D 261/18
US Classification:
514378, 548248
Abstract:
Compounds in accord with Formula I:.
Metabotropic Glutamate Receptor Isoxazole Ligands And Their Use As Potentiators
US Patent:
7888353, Feb 15, 2011
Filed:
Aug 26, 2010
Appl. No.:
12/869263
Inventors:
Joseph Cacciola - Wilmington DE, US
James Empfield - Wilmington DE, US
James Folmer - Wilmington DE, US
Angela M Hunter - Wilmington DE, US
Scott Throner - Wilmington DE, US
James Empfield - Wilmington DE, US
James Folmer - Wilmington DE, US
Angela M Hunter - Wilmington DE, US
Scott Throner - Wilmington DE, US
Assignee:
AstraZeneca AB - Sodertalje
International Classification:
A61K 31/5377, C07D 413/14
US Classification:
5142352, 544137
Abstract:
Compounds in accord with Formula I:.
Metabotropic Glutamate Receptor Isoxazole Ligands And Their Use As Potentiators—286
US Patent:
8148372, Apr 3, 2012
Filed:
Aug 20, 2010
Appl. No.:
12/860330
Inventors:
Joseph Cacciola - Wilmington DE, US
James Empfield - Wilmington DE, US
James Folmer - Wilmington DE, US
Angela M Hunter - Wilmington DE, US
Scott Throner - Wilmington DE, US
James Empfield - Wilmington DE, US
James Folmer - Wilmington DE, US
Angela M Hunter - Wilmington DE, US
Scott Throner - Wilmington DE, US
Assignee:
AstraZeneca AB - Sodertalje
International Classification:
A61K 31/5377, C07D 413/14, A61K 31/422, C07D 261/18
US Classification:
5142352, 514378, 544137, 544140, 548248
Abstract:
Compounds in accord with Formula I:.
4-Substituted Imidazoles
US Patent:
2007010, May 10, 2007
Filed:
Nov 15, 2004
Appl. No.:
10/579609
Inventors:
James Empfield - Wilmington DE, US
Eifion Phillips - Bothwyn PA, US
Scott Throner - Wilmington DE, US
Eifion Phillips - Bothwyn PA, US
Scott Throner - Wilmington DE, US
Assignee:
AstraZeneca AB - Sodertalje
International Classification:
A61K 31/4745, A61K 31/46, A61K 31/4178, C07D 453/02
US Classification:
514304000, 514305000, 514397000, 546125000, 546133000, 548311100
Abstract:
Compounds of formula I:
wherein A and Rare as defined in the specification, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially in the treatment or prophylaxis of psychotic and intellectual impairment disorders.
5-Substituted Imidazoles
US Patent:
2008018, Aug 7, 2008
Filed:
Nov 15, 2004
Appl. No.:
10/579608
Inventors:
James Empfield - Wilmington DE, US
Eifion Phillips - Bothwyn PA, US
Scott Throner - Wilmington DE, US
Eifion Phillips - Bothwyn PA, US
Scott Throner - Wilmington DE, US
Assignee:
ASTRA ZENECA AB - Sodertaije Sweden
International Classification:
A61K 31/439, C07D 453/02, A61P 25/34, A61P 25/16, A61P 25/18, A61P 25/00, A61P 25/28
US Classification:
514305, 546133
Abstract:
Compounds of formula I:wherein A and Rare as defined in the specification, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially in the treatment or prophylaxis of psychotic and intellectual impairment disorders.